Clareo Health | Evaluation of the Efficacy and Safety of Common Sage in Controlling Hot Flashes in Prostate Cancer Patients Treated by Androgen Deprivation
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital, Ghent
With
Farmafyt
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Prostate cancer patients treated with androgen deprivation and experiencing hot flashes.
Karnofsky performance status ≥70%
Age ≥18 years
Informed consent obtained, signed and dated before specific protocol procedures
You may not be if
Other therapy for hot flashes
Mental condition rendering the patient unable to understand the nature, scope, and possible consequences of the study
Patient unlikely to comply with protocol, i.e. uncooperative attitude, inability to complete the diary, inability to return for follow-up visits, and unlikely to complete the study.
